PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Do Board Members of PhRMA Support Importing Unapproved Medication?

Since Americans started importing medications for personal use in larger numbers at the beginning of the last decade, the Pharmaceutical Researchers and Manufacturers of America (PhRMA), Big Pharma, has engaged in media and government relations scare tactics to try and stop them.  Apparently, when it comes to foreign versions of the new FDA-Approved Emflaza, which treats Duchenne Muscular Dystrophy, one board member of PhRMA supports importation!

Last week, I wrote about the decision of drug company Marathon Pharmaceuticals to postpone selling Emflaza over pricing concerns and how the issue shines a bright light on the benefits of personal drug importation. To summarize: some folks are outraged because Emflaza (deflazacort) was launched at a price of $89,000 for a one year supply. This seems insane when foreign versions of deflazacort, which cost 1% that amount (less than $1000), are already imported for personal use.

PhRMA is trying to distance itself from Marathon, just like it did with Martin Shkreli, former CEO of Turning Pharmaceuticals, when the price of Daraprim jumped from $13.50 to $750 a pill overnight. The CEO of Marathon, Jeff Aronin, however, sits on PhRMA’s Board of Directors! Last week, John Carroll of Endpoints News predicted last week that Aronin might be dropped. As of today, he’s still there.

Mr. Aronin wrote a letter to the Duchenne community that fully acknowledged American kids were already being treated with an unapproved foreign version of deflazacort. In his words: “As we all know, deflazacort was being used without FDA approval — and without ever having been approved anywhere in the world for Duchenne — by a very small group of patients (roughly 7 to 9 percent) in the Duchenne community who imported it from overseas.”

But does he support it? I mean, after all, the “score” for Marathon is that once it’s available for sale in the U.S., it will be purchased here. At least for the time being, this PhRMA board member does support it and seems to have no concern whatsoever whether the foreign version is safe and effective, not should he, since, like other medications, it was approved for safety and efficacy elsewhere. In noting that Marathon will “pause our commercialization” of Emflaza,” maintain its Expanded Access Patient Assistance Program, Aronin also state: “Patients currently receiving deflazacort from other sources may continue to have that option.” Damn right.

Is it hypocritical of PhRMA to diss Marathon? After all, brand drug companies jacked prices 130 times the inflation rate in 2015. Forty-five million Americans didn’t fill a prescription in 2016 due to cost. PhRMA will continue its practice of legal bribery and unleash a new, shiny PR campaign about life sciences and innovation — to prevent legislative and regulatory reforms that would lower drug prices. It’s going to take an unpredictable, unexpected populist wave of American anger at drug companies to bring their house down. In the meantime, maybe the people will take a hint from one PhRMA board member and import unapproved and lower cost medications.

Share
Tagged with: , , , , ,

What Emflaza’s Postponed Launch Says about Personal Drug Importation

 

Unapproved but safe and effective…

Personal drug importation works! This week, drug company Marathon announced  it is postponing the launch of Emflaza, its recently FDA-approved version of an off-patent drug called deflazacort, in the face of heavy scrutiny by Senator Bernie Sanders and Congressman Elijah Cummings over its price tag – $89,000 a year. This drug, which treats Duchenne Muscular Dystrophy (DMD), is available under the brand name Calcort in the United Kingdom at about 99% less (about $750) than the current U.S. “postponed” price. Generic versions of deflazacort are also available internationally among verified online pharmacies at an annual price tag of about $650.

For some background on the disease and treatment: DMD is a “genetic disorder characterized by progressive muscle degeneration and weakness.” It mostly afflicts boys, with onset ranging from ages 3-5. It’s caused by the absence of a protein called dystrophin. For more, see the Muscular Dystrophy Association’s (MDA) website. According to the MDA, corticosteroids, including deflazacort, help slow the disease’s progression.

For a critique of the Emflaza price read Sanders and Cummings’ letter. No one could do better than that. Marathon CEO Jeff Aronin attempts to rationalize the price here but it almost reads like an apology. They argue that no consumer will deal with the $89,000 price tag because health insurers only charge a $20 co-pay and they have patient assistance programs to help the uninsured. It’s never that perfect, at all: people always slip through the cracks and we’re not forcing people to go without needed medication or go into bankruptcy to get it. Right?

So now a fist full of truth about this medication and safe online access to affordable medicines to shine a bright light on the lifeline that is personal drug importation… (more…)

Share
Tagged with: , ,

CEO of PharmacyChecker On People’s Pharmacy Radio Talking Safety and Savings on Narrow Therapeutic Index Drugs

Tod Cooperman, MD CEO of PharmacyChecker.com

Joe and Terry Graedon have been helping Americans make better health decisions for the last 40 years, including through their syndicated radio show on National Public Radio called The People’s Pharmacy. As you can imagine, their listeners are interested in prescription drug safety and savings. Our CEO was on their show this past Saturday and I’d like to tell you about it, especially if you want to learn how to save money on brand name drugs.

The CEO of PharmacyChecker.com, Tod Cooperman, MD, is also the founder and president of ConsumerLab.com, the leading evaluator of health and wellness products. ConsuemrLab.com has worked with The People’s Pharmacy in the past to test prescription medications. While I believe that generics sold in the U.S. are usually of the highest quality, equal to or better than generics in most other countries, ConsumerLab.com’s findings show that some generic medications in the U.S. are not always equal to the brand. Due to his expertise is drug quality and his knowledge about drug prices, The People’s Pharmacy brought Dr. Cooperman on to their show last week to talk about Narrow Therapeutic Index (NTI) drugs. Listen to the show! (See minutes 6:50-18:00).

For NTI medications, it’s even more important that the active pharmaceutical ingredient is present in the exact amount required. When NTI medications have too much of the active pharmaceutical ingredient, it can be toxic; but those that have too little may not be adequately efficacious. Most NTI drugs are available in generic form, which usually means they are low cost, even without insurance, and usually lower-priced than in Canada and other countries, too! The opposite holds true for brands.

Some providers are deciding that it’s important for their patients stick with the brand for NTI drugs for the reasons stated above.  But the prices here are often too high. In the radio show, Dr. Cooperman recommends looking internationally for those who can’t afford the brand locally. Americans can often find discounts averaging 80% internationally on Brand name NTI drugs. Last summer, when we read The Graedon’s Guide to Saving Money on Medicines, we noticed the list of NTI drugs and wanted to compare drug prices domestically and internationally. Our research from Fall 2016 is below.

Narrow Therapeutic Index (NTI) Drugs: Brand Name Price Comparison (U.S., Canada, International*)

Per Pill Cost[i] Potential Savings
Medication Name: Brand (Generic) Strength U.S[ii] Canada[iii] NZ/UK[iv] Canada Other Int’l Overall
Tegretol (Carbamazepine) 200mg $2.87 $0.77 $0.57 73% 80% 80%
Cleocin HCl (Clindamycin) [v] 300mg caps $24.00 $3.38  NA 86% NA 86%
Catapres (Clonidine HCl) 0.1mg $3.34 $0.45  NA 86% NA 86%
Sandimmune (Cyclosporine) 100mg /mL  50mL $664.84 $327.98  NA 51% NA 51%
Lanoxin (Digoxin)[vi] 0.125mg $12.54 $0.75  NA 94% NA 94%
Depakote (Divalproex)[vii] 250mg $5.73 $0.90  NA 84% NA 84%
Zarontin (Ethosuximide) 250mg $4.51 $0.66  NA 85% NA 85%
Synthroid (Levothyroxine) 100 mcg (0.1mg) $1.87 $0.35 $0.63 81% 66% 81%
Dilantin (Phenytoin) 100mg $1.45 $0.33 $0.48 77% 67% 77%
Depakene (Valproic acid) 250mg $5.76 $0.93  NA 84% NA 84%
Coumadin (Warfarin) 5mg $3.69 $0.60 NA 84% NA 84%
 Average Savings 81%

[i] Based on three month supply of medication.

[ii] Walgreens, NYC, December 2016

[iii] Prices of international online pharmacies verified by PharmacyChecker.com.

[iv] Prices of international online pharmacies verified by PharmacyChecker.com.

[v] Marketed as Dalacin C in Canad

[vi] Marketed as Toloxin in Canada

[vii] Marketed as Epival in Canada

 

Share
Tagged with: , , ,

Drug Company Patient Assistance Program Information Can be Found on PharmacyChecker.com

Can Big Pharma Help Me Afford My Meds?

People who are not new to this blog know that we are often critical of the pharmaceutical industry because of their actions to stop Americans from buying lower cost medications from international online pharmacies. So, this may come as a surprise…

Today, we announced that we have added a new section on PharmacyChecker.com for consumers to search, find and apply to patient assistance programs, those sponsored by pharmaceutical companies. You can type in the name of your medication and review a very comprehensive collection of these programs, including low-cost, no-cost, and copay programs. The eligibility hurdles are often prohibitive: so please understand that for many programs, if you’re currently earning above the median income in the U.S. it’s likely that you are too rich. (more…)

Share

PhRMA Wants to Share the Blame of High Drug Prices with the Whole Supply Chain

Don’t blame poor little Big Pharma

Big Pharma is in the mood to share! A new report commissioned by the Pharmaceutical Researchers and Manufacturers of America (PhRMA), the trade association representing the world’s largest global pharmaceutical companies, seems to assert that the blame for high drug prices should be shared with pharmacy benefit managers, retail pharmacies, wholesalers, and, I think, even hospitals – and more. It appears that PhRMA’s main target is the pharmaceutical benefit managers.

Noting that President Donald Trump recently said drug companies are “getting away with murder” – I view this report as pharma’s attempt to communicate, “hey, prez, we’re not alone here in being greedy.” The report has merit, which I’ll explain below when looking at the dollar numbers. But as far as the American consumer is concerned: murder is murder. Hey, I’m just using the president’s words. Due to the killing made by pharma and friends (because they’re all friends), 10s of millions of Americans are leaving their scripts unfilled because the prices, one way or the other, are out of reach.

The report is called “The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders.” You can find a summary of it here but this is my take on it. (more…)

Share
Tagged with: ,

Medication Safety is a Weak Argument Against Allowing Personal Prescription Importation

In this blog post I’m going to get personal. Not about me but about importing medication from Canada and other countries. You’ll see what I mean. Last week, Senator Bernie Sanders introduced an amendment to the budget bill, which would have paved the way for future deficit neutral spending to implement new regulations expanding lawful access to lower cost imported medication from wholesalers, pharmacies and individuals. Unfortunately, the amendment was defeated 52-46.

Let’s forget about the fact that drug companies give members of Congress lots of money. OK, I can’t forget: it’s about two billion dollars over the last 15 years. Some senators who voted against the amendment cited their concerns with safety as a basis for their vote. Let me explain why they are wrong, at least when it comes to personal vs. wholesale drug importation. (more…)

Share
Tagged with: , ,

PharmacyCheckerBlog Wins Award for Top 50 in Covering Pharma by Feedspot

PharmacyCheckerBlog.com Awarded Top 50 Pharma Blog Award

PharmacyCheckerBlog was bestowed an award by Feedspot as one of the top 50 blogs covering pharma! Over the past seven years, our blog has covered a variety of areas related to prescription drug prices, safety, policy, and politics. But our blog’s focus is telling Americans the truth about savings and safety related to buying medications from online pharmacies and personal drug importation, and standing up the pharmaceutical industry’s efforts to mislead the American people on these issues. (more…)

Share

Generic Truvada Purchased Online Helps Reduce HIV Infections Among At-Risk Communities in London

Truvada - HIV PrEP Medication

In case you didn’t know, PharmacyChecker is based in New York. We are a proud American company, one that has helped millions of Americans for well over a decade get the information they need to save money safely if choosing to buy lower cost, imported medication online. While my focus is often the American consumer, I’m very much concerned with medicine access needs globally, too.

The fact is that online access to affordable medication is helping consumers throughout the world. We’re going to look at one very interesting and uplifting example from the United Kingdom, where people in at-risk communities are saving themselves from contracting HIV through the safe purchase of medication over the Internet and importing it for personal use.

The title of an article in the New Scientist pinpoints the gist of what’s going on: “Massive drop in HIV rates may be due to Internet Drugs.” In late 2016, four health clinics in London saw a dramatic drop in new HIV infections of 40% among gay men over a 12-month period. That period corresponded with the launch of I Want PrEP Now (https://www.iwantprepnow.co.uk/), a non-profit initiative that helps people safely buy generic Truvada online. While it’s possible that other factors are at play, public health experts attributed the drop in new HIV infections to the ability of people to obtain generic Truvada affordably through the Internet. I cannot vouch for the online pharmacies recommended through I Want PrEP because we have not verified them in the PharmacyChecker Verification Program, but read on to see amazing evidence of the safety and efficacy of the medications ordered. (more…)

Share
Tagged with: , ,

Would Big Pharma Create Fake News to Scare Americans Away from Online Pharmacies Abroad?

It’s time to get real

In 2005, as reported here, an executive from the Pharmaceutical Researchers and Manufacturers of America (PhRMA or Big Pharma), agreed to commission, to the tune of $300,000, the writing of a fictional novel in which Muslim terrorists poison prescription drugs in Canada to kill Americans who – seeking affordable medication –  buy drugs from Canada. The deal with the publisher didn’t work out. As the authors tell it, PhRMA offered money to shut them up but they said no. They instead wrote a book about a pharmaceutical company who poisoned Canadian drugs and made it look like Muslim terrorists did it. Nope, I couldn’t make this up. That book – The Karasik Conspiracy – is available on Amazon.

Fake news is in the news a lot lately! Like fake news, efforts to dissuade Americans from obtaining safe lower cost medication through personal drug importation can have dangerous consequences: people scared away from safe medication they can afford. There are – in fact –  very safe international online pharmacies and dangerous rogue pharmacy sites. Stick to the former avoid the latter. There are tens of millions of Americans not taking medications because of cost — so it’s time to get real.  (more…)

Share
Tagged with: , , , , ,

Nineteen million Americans Have Imported Medication for Personal Use to Pay Less and Happy New Year

New Year's Eve Times Square CrowdAs we close out 2016, I’m not surprised to be reporting and commenting on new survey data by the Kaiser Family Foundation showing that 19 million Americans have purchased and imported lower cost medication from Canada and other countries. I suspect the number is higher and I’m sure it’s not high enough, as I’ll discuss at the conclusion of this post.

First, as reported in Kaiser Health News: “As drug prices have spiraled upward in the past decade, tens of millions of generally law-abiding Americans have committed an illegal act in response: They have bought prescriptions outside the U.S. and imported them.” The Kaiser story also reports that many such purchases are made online and while the FDA warns that many online pharmacies are not safe, “…many medicines purchased from another country are the same as the ones patients buy in the U.S.” That’s all true. The key to safety when buying medications internationally is only purchasing from properly verified websites, ones approved by PharmacyChecker.

Just to recap why importation is a lifeline, let’s look at some highlights from recent data. (more…)

Share
Tagged with: , ,